Whittier Trust Co. of Nevada Inc. boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 3.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 126,463 shares of the exchange traded fund’s stock after purchasing an additional 4,378 shares during the quarter. Whittier Trust Co. of Nevada Inc. owned about 0.20% of SPDR S&P Biotech ETF worth $16,288,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also bought and sold shares of XBI. Financial Life Planners bought a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter worth $27,000. Intesa Sanpaolo Wealth Management bought a new position in SPDR S&P Biotech ETF in the fourth quarter valued at $30,000. SHP Wealth Management bought a new position in SPDR S&P Biotech ETF in the fourth quarter valued at $31,000. Finally, Legacy Wealth Managment LLC ID purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $32,000.
SPDR S&P Biotech ETF Price Performance
Shares of XBI stock opened at $160.46 on Monday. The business has a 50-day moving average price of $137.41 and a two-hundred day moving average price of $130.02. SPDR S&P Biotech ETF has a 12-month low of $83.02 and a 12-month high of $160.82. The firm has a market cap of $10.85 billion, a P/E ratio of 11.47 and a beta of 0.82.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Visa’s Open USD Push Puts Circle’s Stablecoin Moat Under Pressure
- This Under-the-Radar Industrial Is Quietly Powering AI
- Why Microsoft Looks Like the Best Big Tech Trade for H2 2026
- Strategy’s Bitcoin Pivot Gives Investors a New Reason to Watch Preferred Shares
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
